Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
Clinical trial NCT03304379 · COMPLETED
Trial details
- NCT number
- NCT03304379
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-26
- Primary completion
- 2019-12-13
- Enrollment
- 1650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.